Products

What will AGI do for Alteplase?

This classification denotes a differentiation inducer with the molecular formula C2569H3894N746O781S40, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 1RXS4UE564, more generally known as alteplase. European Medicines Agency schedules alteplase in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05378MIG. The term ALTEPLASE is an International Non-Proprietary Name or INN. see WHO INN reference publication, Volume 3, no. 3, 1989, list 29. ALTEPLASE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule alteplase under HS 35079090 and SITC 51691. As of Q4 2014, ALTEPLASE remains the US FDA Preferred Term for this commodity. Alteplase bears US NLM identifiers UMLS ID C0032143 and NCI Concept Code C39607. SMILES: none.